ChiCTR2600126097 版本V1.0 版本创建时间2026/06/03 16:52:34 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600126097 

最近更新日期:

Date of Last Refreshed on:

2026-06-03 16:41:11 

注册时间:

Date of Registration:

2026-06-03 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

小儿全麻维持期间短暂脑电图α功率损失以及其与术后疼痛的相关性研究

Public title:

Transient electroencephalogram alpha power loss during maintenance of general anesthesia in children and its correlation with postoperative pain

注册题目简写:

小儿全麻下α脱落及与术后疼痛的相关性研究

English Acronym:

Alpha dropout during maintenance of general anaesthesia in children and its correlation with postoperative pain

研究课题的正式科学名称:

小儿全麻维持期间短暂脑电图α功率损失以及其与术后疼痛的相关性研究

Scientific title:

Transient electroencephalogram alpha power loss during maintenance of general anesthesia in children and its correlation with postoperative pain

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王骏羲 

研究负责人:

喻文立 

Applicant:

WANG JUNXI 

Study leader:

YU WENLI 

申请注册联系人电话:

Applicant telephone:

+86 176 1619 1670

研究负责人电话:

Study leader's telephone:

+86 139 2009 8326

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2860342723@qq.com

研究负责人电子邮件:

Study leader's E-mail:

yzxyuwenli@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市第一中心医院(天津市南开区卫津路94号)

研究负责人通讯地址:

天津市第一中心医院(天津市南开区卫津路94号)

Applicant address:

Tianjin First Central Hospital (No.94 Weijin Road, Nankai District, Tianjin)

Study leader's address:

Tianjin First Central Hospital (No.94 Weijin Road, Nankai District, Tianjin)

申请注册联系人邮政编码:

Applicant postcode:

300110

研究负责人邮政编码:

Study leader's postcode:

300110

申请人所在单位:

天津市第一中心医院

Applicant's institution:

Tianjin First Central Hospital

研究负责人所在单位:

天津市第一中心医院

Affiliation of the Leader:

Tianjin First Central Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

科伦审2026-102

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津市第一中心医院科研伦理委员会

Name of the ethic committee:

Research Ethics Committee of Tianjin First Central Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-04-28 00:00:00

伦理委员会联系人:

巩欣媛

Contact Name of the ethic committee:

GONG XINYUAN

伦理委员会联系地址:

天津市西青区保山西道2号

Contact Address of the ethic committee:

No.2 Baoshan West Road, Xiqing District, Tianjin

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23628843

伦理委员会联系人邮箱:

Contact email of the ethic committee:

tfch_ethic@126.com

研究实施负责(组长)单位:

天津市第一中心医院

Primary sponsor:

Tianjin First Central Hospital

研究实施负责(组长)单位地址:

天津市南开区卫津路94号

Primary sponsor's address:

No.94 Weijin Road, Nankai District, Tianjin

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津市 / 市辖区 / 南开区

市(区县):

天津市 / 市辖区 / 南开区

Country:

China

Province:

Tianjin

City:

/ /

单位(医院):

天津市第一中心医院

具体地址:

天津市南开区卫津路94号

Institution
hospital:

Tianjin First Central Hospital

Address:

No.94 Weijin Road, Nankai District, Tianjin

经费或物资来源:

津门医学英才任务书

Source(s) of funding:

Task Book of Jinmen Medical Talents

Target disease:

Pain

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

探究小儿全麻下短暂的α功率损失的特点及与术后疼痛的相关性  

Objectives of Study:

To investigate the characteristics of transient alpha power loss under general anesthesia in children and its correlation with postoperative pain

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.1岁≤年龄<18岁,性别不限 2.18 kg/m2≤体重指数≤30 kg/m2 3.术前 ASA 分级 I~Ⅱ 级 4.患者预计住院时间>3天 5.监护人同意患儿参与实验并签署知情同意书

Inclusion criteria

1. 1 year <= age < 18 years, regardless of gender; 2. 18 kg/m^2 <= body mass index <= 30 kg/m^2; 3. Preoperative ASA Grade I ~ II; 4. Expected length of hospital stay > 3 days; 5. The guardian consented to the child's participation in the experiment and signed the informed consent form.

排除标准:

1. 存在神经系统疾病(如癫痫、脑损伤史)、听力障碍(影响疼痛评估量表理解)或认知发育迟缓; 2. 术前存在慢性疼痛病史(如反复发作的腹痛、手术切口区域曾有长期疼痛); 3. 在麻醉诱导前使用镇静药; 4. 曾有麻醉药物(丙泊酚、瑞芬太尼)过敏史; 5. 计划进行开颅手术或涉及中枢神经系统的手术; 6. 术后需立即转入ICU且无法按计划完成疼痛评估。

Exclusion criteria:

1. Presence of neurological disorders (e.g., epilepsy, history of brain injury), hearing impairment (affecting pain assessment scale understanding), or cognitive retardation; 2. Preoperative history of chronic pain (such as recurrent abdominal pain, long-term pain in the surgical incision area); 3. Use sedatives before anesthesia induction; 4. History of allergy to narcotic drugs (propofol, remifentanil); 5. Planning for craniotomy or surgery involving the central nervous system; 6. Immediate transfer to ICU after surgery and failure to complete the pain assessment document as planned.

研究实施时间:

Study execute time:

From 2026-05-30 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-03 00:00:00 To 2026-12-31 00:00:00  

干预措施:

Interventions:

组别:

观察组

样本量:

330

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

天津市 

市(区县):

 

Country:

China 

Province:

Tianjin 

City:

 

单位(医院):

天津市第一中心医院 

单位级别:

三甲 

Institution
hospital:

Tianjin First Central Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

天津市 

市(区县):

 

Country:

China 

Province:

Tianjin 

City:

 

单位(医院):

天津市儿童医院 

单位级别:

三甲 

Institution
hospital:

Tianjin Children's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脑电图α功率下降

指标类型:

主要指标

Outcome:

Electroencephalogram alpha power decreased

Type:

Primary indicator

测量时间点:

麻醉诱导前至苏醒后

测量方法:

采用脑电双频指数记录患者的额叶脑电图

Measure time point of outcome:

Before induction of anesthesia to after awakening

Measure method:

Electroencephalogram of frontal lobe was recorded by bispectral EEG index

指标中文名:

术后疼痛程度

指标类型:

次要指标

Outcome:

Postoperative pain degree

Type:

Secondary indicator

测量时间点:

测量方法:

视觉模拟评分(脸谱)/FLACC量表

Measure time point of outcome:

Measure method:

Facial Visual Analogue Scale(F-VAS)/Face,Legs,Activity,Cry,Consolability Scale(FlACC Scale)

指标中文名:

心率

指标类型:

次要指标

Outcome:

Heart rate

Type:

Secondary indicator

测量时间点:

麻醉诱导前至苏醒后

测量方法:

心电图

Measure time point of outcome:

Before induction of anesthesia to after awakening

Measure method:

Electrocardiogram

指标中文名:

血压

指标类型:

次要指标

Outcome:

Blood pressure

Type:

Secondary indicator

测量时间点:

麻醉诱导前至苏醒后

测量方法:

无创血压监测/有创动脉血压监测

Measure time point of outcome:

Before induction of anesthesia to after awakening

Measure method:

Non-Invasive Blood Pressure/Arterial Blood Pressure

指标中文名:

儿童术后恢复质量量表

指标类型:

次要指标

Outcome:

Quality scale of postoperative recovery in children

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后补救镇痛的药物使用量

指标类型:

次要指标

Outcome:

Dose of drugs used for postoperative rescue analgesia

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

None

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

None

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 1 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

联系作者

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Contact the author

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF table

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-06-03 16:41:11